No Data
Guangbo Group Stock Co., Ltd.'s (SZSE:002103) Stock Is Going Strong: Is the Market Following Fundamentals?
May 7 A-share investment lightning rod︱LBX Pharmacy Chain Joint Stock: The controlling Shareholder Medicine Group intends to reduce its Shareholding by no more than 3%.
China Electric Power shareholders, China Electric Kunrun Fund and China Electric Development Fund, plan to reduce their total shareholding by no more than 3%; Guangbo Group Stock Director Ren Hangzhong plans to reduce his shareholding by no more than 1.97%; Shanghai Laimu Electronics Chairman and General Manager Zhu Xin'ai plans to reduce his shareholding by no more than 2.31%; LBX Pharmacy Chain Joint Stock controlling shareholder Pharmaceutical Group plans to reduce its shareholding by no more than 3%; Beijing Sifang Automation controlling shareholder Sifang Electric plans to reduce its shareholding by no more than 3%; Fujian Zitian Media Technology received a notice of investigation from the Securities Regulatory Commission for failing to disclose periodic reports within the stipulated time; Zhejiang Zhaofeng Mechanical And Electronic has not yet started any Siasun Robot&Automation related business; Jiangsu Riying Electronics currently has income from its unmanned robot related business.
Guangbo Co., Ltd.: Report for the first quarter of 2025
Guangbo Co., Ltd.: 2024 Annual Report Summary
Guangbo Co., Ltd.: 2024 Annual Report
Guangbo Group Stock (002103.SZ): Proposing to authorize the Board of Directors to issue Stocks to specific recipients through a simplified procedure at the Shareholders' Meeting.
On April 11, Gelonghui announced that Guangbo Group Stock (002103.SZ) disclosed that, in accordance with the "Measures for the Administration of Securities Issuance and Registration of Listed Companies" and the "Rules for the Listing Review of Securities Issuance of Listed Companies on the Shenzhen Stock Exchange," the Board of Directors proposed that the shareholders' meeting authorize the Board of Directors to decide on the matter of issuing A-shares to specific objects for a total financing amount not exceeding RMB 0.3 billion and not exceeding 20% of the net assets as of the end of the most recent year. The authorization period is from the date of approval at the 2024 annual shareholders' meeting until the date of the 2025 annual shareholders' meeting.
Returns On Capital At Guangbo Group Stock (SZSE:002103) Have Hit The Brakes
